![Management of patients with multidrug-resistant/extensively drug-resistant tuberculosis in Europe: a TBNET consensus statement | European Respiratory Society Management of patients with multidrug-resistant/extensively drug-resistant tuberculosis in Europe: a TBNET consensus statement | European Respiratory Society](https://erj.ersjournals.com/content/erj/44/1/23/F2.large.jpg)
Management of patients with multidrug-resistant/extensively drug-resistant tuberculosis in Europe: a TBNET consensus statement | European Respiratory Society
![Drug-resistant tuberculosis: what is the situation, what are the needs to roll it back | AMR Control Drug-resistant tuberculosis: what is the situation, what are the needs to roll it back | AMR Control](http://resistancecontrol.info/wp-content/uploads/2017/07/fig3a.jpg)
Drug-resistant tuberculosis: what is the situation, what are the needs to roll it back | AMR Control
![Treatment efficacy of drug-resistant tuberculosis in Bashkortostan, Russia: A retrospective cohort study - International Journal of Infectious Diseases Treatment efficacy of drug-resistant tuberculosis in Bashkortostan, Russia: A retrospective cohort study - International Journal of Infectious Diseases](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/70c0cb31-62c6-4245-9dfe-7893d5da3232/gr3.jpg)
Treatment efficacy of drug-resistant tuberculosis in Bashkortostan, Russia: A retrospective cohort study - International Journal of Infectious Diseases
![Figure 1 from Linkage of Presumptive Multidrug Resistant Tuberculosis (MDR- TB) Patients to Diagnostic and Treatment Services in Cambodia | Semantic Scholar Figure 1 from Linkage of Presumptive Multidrug Resistant Tuberculosis (MDR- TB) Patients to Diagnostic and Treatment Services in Cambodia | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/adb7a6577a7d8e50a933974a1b20afe6381c8dda/3-Figure1-1.png)
Figure 1 from Linkage of Presumptive Multidrug Resistant Tuberculosis (MDR- TB) Patients to Diagnostic and Treatment Services in Cambodia | Semantic Scholar
![Factors associated with treatment outcome in 64 HIV negative patients with multidrug resistant tuberculosis - Ünsal - Journal of Thoracic Disease Factors associated with treatment outcome in 64 HIV negative patients with multidrug resistant tuberculosis - Ünsal - Journal of Thoracic Disease](https://cdn.amegroups.cn/journals/pbpc/files/journals/2/articles/1289/public/1289-PB5-R1.png)
Factors associated with treatment outcome in 64 HIV negative patients with multidrug resistant tuberculosis - Ünsal - Journal of Thoracic Disease
![Extensively drug-resistant tuberculosis in India: Current evidence on diagnosis & management Prasad R, Singh A, Balasubramanian V, Gupta N - Indian J Med Res Extensively drug-resistant tuberculosis in India: Current evidence on diagnosis & management Prasad R, Singh A, Balasubramanian V, Gupta N - Indian J Med Res](https://www.ijmr.org.in/articles/2017/145/3/images/IndianJMedRes_2017_145_3_271_211672_t4.jpg)
Extensively drug-resistant tuberculosis in India: Current evidence on diagnosis & management Prasad R, Singh A, Balasubramanian V, Gupta N - Indian J Med Res
![Interim treatment outcomes in multidrug-resistant tuberculosis patients treated sequentially with bedaquiline and delamanid - International Journal of Infectious Diseases Interim treatment outcomes in multidrug-resistant tuberculosis patients treated sequentially with bedaquiline and delamanid - International Journal of Infectious Diseases](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/asset/d2041c3c-89f5-4341-9ab4-a250899b94fe/gr1.jpg)
Interim treatment outcomes in multidrug-resistant tuberculosis patients treated sequentially with bedaquiline and delamanid - International Journal of Infectious Diseases
![Interim treatment outcomes in multidrug-resistant tuberculosis using bedaquiline and/or delamanid in South Korea - Respiratory Medicine Interim treatment outcomes in multidrug-resistant tuberculosis using bedaquiline and/or delamanid in South Korea - Respiratory Medicine](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/asset/142a99ca-c34e-4700-866b-a3d3b604aebd/gr1.jpg)
Interim treatment outcomes in multidrug-resistant tuberculosis using bedaquiline and/or delamanid in South Korea - Respiratory Medicine
![Intermittent treatment interruption and its effect on multidrug resistant tuberculosis treatment outcome in Ethiopia | Scientific Reports Intermittent treatment interruption and its effect on multidrug resistant tuberculosis treatment outcome in Ethiopia | Scientific Reports](https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fs41598-019-56553-1/MediaObjects/41598_2019_56553_Fig1_HTML.png)
Intermittent treatment interruption and its effect on multidrug resistant tuberculosis treatment outcome in Ethiopia | Scientific Reports
![Multidrug-resistant tuberculosis treatment failure detection depends on monitoring interval and microbiological method | European Respiratory Society Multidrug-resistant tuberculosis treatment failure detection depends on monitoring interval and microbiological method | European Respiratory Society](https://erj.ersjournals.com/content/erj/early/2016/08/31/13993003.00462-2016/F1.large.jpg)
Multidrug-resistant tuberculosis treatment failure detection depends on monitoring interval and microbiological method | European Respiratory Society
![Multidrug-resistant tuberculosis/rifampicin-resistant tuberculosis: Principles of management Prasad R, Gupta N, Banka A - Lung India Multidrug-resistant tuberculosis/rifampicin-resistant tuberculosis: Principles of management Prasad R, Gupta N, Banka A - Lung India](https://www.lungindia.com/articles/2018/35/1/images/LungIndia_2018_35_1_78_221739_t1.jpg)
Multidrug-resistant tuberculosis/rifampicin-resistant tuberculosis: Principles of management Prasad R, Gupta N, Banka A - Lung India
![WHO Consolidated Guidelines on Tuberculosis, Module 4: Treatment - Drug-Resistant Tuberculosis Treatment - PAHO/WHO | Pan American Health Organization WHO Consolidated Guidelines on Tuberculosis, Module 4: Treatment - Drug-Resistant Tuberculosis Treatment - PAHO/WHO | Pan American Health Organization](https://www.paho.org/sites/default/files/styles/document_thumb/public/2020-06/consolidated-handbook-tb-mdr.jpg?itok=X_qIgqXL)
WHO Consolidated Guidelines on Tuberculosis, Module 4: Treatment - Drug-Resistant Tuberculosis Treatment - PAHO/WHO | Pan American Health Organization
PLOS ONE: Community-based MDR-TB care project improves treatment initiation in patients diagnosed with MDR-TB in Myanmar
![Treatment of isoniazid-resistant tuberculosis with first-line drugs: a systematic review and meta-analysis - The Lancet Infectious Diseases Treatment of isoniazid-resistant tuberculosis with first-line drugs: a systematic review and meta-analysis - The Lancet Infectious Diseases](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/6682d1a2-255c-4cd9-bced-003e299e50d7/gr1_lrg.gif)
Treatment of isoniazid-resistant tuberculosis with first-line drugs: a systematic review and meta-analysis - The Lancet Infectious Diseases
![Improved treatment outcome of multidrug-resistant tuberculosis with the use of a rapid molecular test to detect drug resistance in China - International Journal of Infectious Diseases Improved treatment outcome of multidrug-resistant tuberculosis with the use of a rapid molecular test to detect drug resistance in China - International Journal of Infectious Diseases](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/asset/641aa5b2-ad2d-4e89-9d19-ed9a63de521f/gr1.jpg)
Improved treatment outcome of multidrug-resistant tuberculosis with the use of a rapid molecular test to detect drug resistance in China - International Journal of Infectious Diseases
![Management of multidrug-resistant tuberculosis with shorter treatment regimen in Niger: Nationwide programmatic achievements - Respiratory Medicine Management of multidrug-resistant tuberculosis with shorter treatment regimen in Niger: Nationwide programmatic achievements - Respiratory Medicine](https://els-jbs-prod-cdn.jbs.elsevierhealth.com/cms/attachment/d7110935-972e-4527-9542-4d996def8ba8/gr1.jpg)